1. Home
  2. ELOG vs QNRX Comparison

ELOG vs QNRX Comparison

Compare ELOG & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

HOLD

Current Price

$0.51

Market Cap

9.0M

Sector

Industrials

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$6.90

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOG
QNRX
Founded
2006
2018
Country
China
United States
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0M
9.2M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
ELOG
QNRX
Price
$0.51
$6.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
80.9K
947.0K
Earning Date
07-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$3.25
52 Week High
$3.07
$41.80

Technical Indicators

Market Signals
Indicator
ELOG
QNRX
Relative Strength Index (RSI) 27.42 61.60
Support Level $0.45 $4.23
Resistance Level $0.98 $8.25
Average True Range (ATR) 0.07 0.47
MACD -0.01 -0.03
Stochastic Oscillator 19.19 57.31

Price Performance

Historical Comparison
ELOG
QNRX

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: